Clinical Trial Update: Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the potential benefits of itopride for metabolic-associated fatty liver disease (MAFLD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatty Liver Disease
• Metabolic-associated Fatty Liver Disease

Drugs mentioned

• itopride (itopride)

Snippet

Sponsor: October 6 University | Conditions: Fatty Liver Disease, Fatty Liver | Phase 2 | Status: UNKNOWN